Clinical Trials for Grade 3a Follicular Lymphoma

Find clinical trials for grade 3a follicular lymphoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

NCT ID: NCT06948786

The PROMOTE-FL trial is a clinical study looking at two medications, pirtobrutinib and mosunetuzumab, to see how well they work together in treating patients with grades 1-3a follicular lymphoma (F...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

NCT ID: NCT04450173

This clinical trial is studying a combination of three medications—obinutuzumab, ibrutinib, and venetoclax—to see how well they work together for patients with previously untreated stage II-IV foll...

Recruiting

Phase: PHASE2 Type: interventional Locations: Los Angeles, California, United States, Sacramento, California, United States +2 more

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

NCT ID: NCT04257578

This clinical trial is investigating a new treatment approach for patients with various types of B-cell lymphoma, including diffuse large B-cell lymphoma and transformed follicular lymphoma. The st...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

NCT ID: NCT04883437

This clinical trial is studying a combination of two medications, acalabrutinib and obinutuzumab, to see how effective they are in treating patients with certain types of previously untreated indol...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

NCT ID: NCT06442475

This clinical trial is studying a medication called mosunetuzumab to see how safe and effective it is for treating patients with certain types of slow-growing B-cell lymphoma, including follicular ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma

NCT ID: NCT06471738

This clinical trial is studying a combination of three medications—zanubrutinib, rituximab, and venetoclax—aimed at treating patients with previously untreated follicular lymphoma, a type of blood ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions